Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

<div>(a) The common gene sets and pathways among the 3 subtypes. (b) The clinical characteristic and the expression of 93 intersected gene sets and pathways among the 3 different PDAC subtypes.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 

Figure 4 | Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 